Literature DB >> 3167530

Blood transfusion and infectious complications following colorectal cancer surgery.

P I Tartter1.   

Abstract

Blood transfusion has been linked to clinical phenomena attributable to immune suppression. We prospectively studied the relationship between perioperative blood transfusion and postoperative infectious complications in 343 consecutive patients undergoing surgery for colorectal cancer. Of the 134 patients who received transfusions 33 (24.6 per cent) developed infectious complications compared with 9 (4.3 per cent) of the 209 patients who did not receive blood (P less than 0.0001). The mean number of units of blood received by patients who developed infectious complications significantly exceeded the number for patients without infectious complications (2.31 versus 0.74, P less than 0.0001). The association of transfusion with infections was highly significant (P less than 0.0001) after controlling for age, sex, blood loss, procedure, tumour differentiation, stage, admission haematocrit, duration of surgery, length of the specimen and tumour size. Blood transfusion appears to be an independent risk factor for postoperative infectious complications.

Entities:  

Mesh:

Year:  1988        PMID: 3167530     DOI: 10.1002/bjs.1800750822

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  26 in total

1.  Risk factors for surgical site infection after elective resection of the colon and rectum: a single-center prospective study of 2,809 consecutive patients.

Authors:  R Tang; H H Chen; Y L Wang; C R Changchien; J S Chen; K C Hsu; J M Chiang; J Y Wang
Journal:  Ann Surg       Date:  2001-08       Impact factor: 12.969

2.  [Anastomotic leakage in the gastrointestinal tract-repair and prognosis].

Authors:  M Stumpf; U Klinge; P R Mertens
Journal:  Chirurg       Date:  2004-11       Impact factor: 0.955

3.  Large bowel cancer: the effect of perioperative blood transfusion on outcome.

Authors:  S Cheslyn-Curtis; L P Fielding; R Hittinger; J S Fry; R K Phillips
Journal:  Ann R Coll Surg Engl       Date:  1990-01       Impact factor: 1.891

4.  Occurrence of intraperitoneal septic complications after hepatic resections between 1985 and 1990.

Authors:  T Matsumata; K Yanaga; M Shimada; K Shirabe; A Taketomi; K Sugimachi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

5.  Intraoperative fluid administration is associated with perioperative outcomes in pancreaticoduodenectomy: a single center retrospective analysis.

Authors:  Oliver S Eng; Julie Goswami; Dirk Moore; Chunxia Chen; Christopher J Gannon; David A August; Darren R Carpizo
Journal:  J Surg Oncol       Date:  2013-08-01       Impact factor: 3.454

6.  Postoperative bleeding risk prediction for patients undergoing colorectal surgery.

Authors:  David Chen; Naveed Afzal; Sunghwan Sohn; Elizabeth B Habermann; James M Naessens; David W Larson; Hongfang Liu
Journal:  Surgery       Date:  2018-07-20       Impact factor: 3.982

7.  Identification of predictive factors for perioperative blood transfusion in colorectal resection patients.

Authors:  Justin Kim; Viken Konyalian; Richard Huynh; Raj Mittal; Michael Stamos; Ravin Kumar
Journal:  Int J Colorectal Dis       Date:  2007-09-04       Impact factor: 2.571

8.  Transfusion-associated immunomodulation: Quantitative changes in cytokines as a measure of immune responsiveness after one time blood transfusion in neurosurgery patients.

Authors:  Prashant Pandey; Rajendra Chaudhary; Amita Aggarwal; Raj Kumar; Dheeraj Khetan; Anupam Verma
Journal:  Asian J Transfus Sci       Date:  2010-07

Review 9.  Transfusion-associated bacterial sepsis.

Authors:  S J Wagner; L I Friedman; R Y Dodd
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

10.  Predictive factors for perioperative blood transfusions in laparoscopic colorectal surgery.

Authors:  Yasmin Abu-Ghanem; Hussein Mahajna; Ronen Ghinea; Ian White; Roy Inbar; Shmuel Avital
Journal:  Int J Colorectal Dis       Date:  2014-04-16       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.